(Q47807758)

5 February 2018

title

Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection (English)

1 reference

5 February 2018

main subject

Coccidioides posadasii

object named as

Coccidioides posadasii

1 reference

Jianmin Xue

1 reference

5 February 2018

Chiung-Yu Hung

series ordinal

1 reference

5 February 2018

Jieh-Juen Yu

series ordinal

1 reference

5 February 2018

Garry T Cole

series ordinal

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 2005

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

1 reference

5 February 2018

issue

1 reference

5 February 2018

page(s)

3535-3544

1 reference

5 February 2018

A vaccine against coccidioidomycosis is justified and attainable

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Cost-effectiveness of a potential vaccine for Coccidioides immitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Protective immunity in coccidioidomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Pattern of 39,500 serologic tests in coccidioidomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Laser-controlled microdissection of tissues opens a window of new opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Evaluation of fungal burden in experimental paracoccidioidomycosis by using the fluorescent dye Blankophor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Type 1/Type 2 immunity in infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Interleukin-5 and eosinophils as therapeutic targets for asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

CpG motifs in bacterial DNA and their immune effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

CpG motifs: the active ingredient in bacterial extracts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Development of a leishmaniasis vaccine: the importance of MPL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

Interleukin-12 regulation of host defenses against Coccidioides immitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.147

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.01.147

1 reference

5 February 2018

1 reference

5 February 2018